These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 13450735)

  • 1. The L.E. phenomenon in rheumatoid arthritis.
    PARR LJ; SHIPTON EA; BENJAMIN P; WHITE PH
    Med J Aust; 1957 Jun; 44(26):900-5. PubMed ID: 13450735
    [No Abstract]   [Full Text] [Related]  

  • 2. CRP and the disposal of dying cells: consequences for systemic lupus erythematosus and rheumatoid arthritis.
    Vogt B; Führnrohr B; Müller R; Sheriff A
    Autoimmunity; 2007 Jun; 40(4):295-8. PubMed ID: 17516213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The L.E. phenomenon in rheumatoid arthritis.
    FRIEDMAN IA; SICKLEY JF; POSKE RM; BLACK A; BRONSKY D; HARTZ WH; FELDHAKE C; REEDER PS; KATZ EM
    Ann Intern Med; 1957 Jun; 46(6):1113-36. PubMed ID: 13435660
    [No Abstract]   [Full Text] [Related]  

  • 4. [Simple, sensitive & reliable method of releasing L.E. phenomenon by mechanical damage to leukocytes of the substratum with special reference to findings in lupus erythematosus and in chronic polyarthritis].
    MARMONT A; PIUMA MA; CAPPONI G
    Schweiz Med Wochenschr; 1957 Oct; 87(39-40):1253-7. PubMed ID: 13486002
    [No Abstract]   [Full Text] [Related]  

  • 5. Significance of the L.E. phenomenon in chronic evolutive polyarthritis.
    GOSLINGS J; HIJMANS W
    J Belge Med Phys Rhumatol; 1958; 13(2):113-25. PubMed ID: 13563425
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical studies of the L.E. phenomenon in chronic evolutive polyarthritis].
    GOSLINGS J
    Reumatismo; 1958; 10(1):1-6. PubMed ID: 13554963
    [No Abstract]   [Full Text] [Related]  

  • 7. Prevalence and factors associated with headache in patients with systemic lupus erythematosus.
    Weder-Cisneros ND; Téllez-Zenteno JF; Cardiel MH; Guibert-Toledano M; Cabiedes J; Velásquez-Paz AL; García-Ramos G; Cantú C
    Cephalalgia; 2004 Dec; 24(12):1031-44. PubMed ID: 15566417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Microtechnic for demonstration of the lupus erythematosus phenomenon. Comparison of various technics with our own highly sensitive technic].
    Beickert A; Döge H; Döge B; Dobenecker H; Frank U
    Z Gesamte Inn Med; 1968 Jul; 23(13):396-9. PubMed ID: 4175985
    [No Abstract]   [Full Text] [Related]  

  • 9. L.E. cell phenomenon.
    Yadav MS; Mehrotra GC; Chhabra OP
    J Indian Med Assoc; 1967 Mar; 48(5):199-202. PubMed ID: 4166961
    [No Abstract]   [Full Text] [Related]  

  • 10. A functional Ser(413)/Ser(413) PAI-2 polymorphism is associated with susceptibility and damage index score in systemic lupus erythematosus.
    Palafox-Sánchez CA; Vázquez-Del Mercado M; Orozco-Barocio G; García-De la Torre I; Torres-Carrillo N; Torres-Carrillo NM; Illades-Aguiar B; Muñoz-Valle JF
    Clin Appl Thromb Hemost; 2009; 15(2):233-8. PubMed ID: 18818228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C-reactive protein and systemic lupus erythematosus.
    Gaitonde S; Samols D; Kushner I
    Arthritis Rheum; 2008 Dec; 59(12):1814-20. PubMed ID: 19035410
    [No Abstract]   [Full Text] [Related]  

  • 12. The L.E. test in patients presenting the clinical picture of rheumatoid arthritis.
    ROSS SW; CLARDY EK
    South Med J; 1956 Jun; 49(6):553-9. PubMed ID: 13324450
    [No Abstract]   [Full Text] [Related]  

  • 13. Systemic lupus erythematosus evolving into rheumatoid arthritis.
    Rothfield NF; Lim AA
    J Rheumatol; 2006 Jan; 33(1):188-90. PubMed ID: 16395767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [On the problem of appearance of LE cells and toxic granulation in peripheral blood of patients with chronic progressive rheumatism].
    DUBROWSKA D
    Reumatol Pol; 1960; 3():355-9. PubMed ID: 13724681
    [No Abstract]   [Full Text] [Related]  

  • 15. [The predictive value of autoantibodies in disseminating lupus erythematosus and rheumatoid arthritis].
    Dijkmans BA; van Schaardenburg D; van der Horst-Bruinsma IE; Reesink HW; Vandenbroucke JP; Boers M
    Ned Tijdschr Geneeskd; 2005 Mar; 149(13):688-93. PubMed ID: 15819133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of anti-3-nitrotyrosine antibodies in the joint synovial fluid of patients with rheumatoid arthritis, osteoarthritis and systemic lupus erythematosus.
    Khan F; Siddiqui AA
    Clin Chim Acta; 2006 Aug; 370(1-2):100-7. PubMed ID: 16513103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Analysis of the acid glycoprotein heterogeneity in patients with arthritis].
    Domysławska I; Lewandowski B; Kita K; Klimiuk PA; Sierakowski S
    Pol Merkur Lekarski; 2004 Oct; 17(100):349-52. PubMed ID: 15690699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atherosclerosis in rheumatoid arthritis and systemic lupus erythematosus.
    Haque S; Mirjafari H; Bruce IN
    Curr Opin Lipidol; 2008 Aug; 19(4):338-43. PubMed ID: 18607179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does systemic lupus erythematosus frequently simulate rheumatoid arthritis.
    LENOCH F; VOJTISEK O; KOCIAN I; MARSIKOVA L
    Acta Med Scand Suppl; 1958; 341():89-100. PubMed ID: 13605632
    [No Abstract]   [Full Text] [Related]  

  • 20. Accelerated atherosclerosis in rheumatoid arthritis and systemic lupus erythematosus.
    Farzaneh-Far A; Roman MJ
    Int J Clin Pract; 2005 Jul; 59(7):823-4. PubMed ID: 15963210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.